Studying Evinacumab, a monoclonal antibody agent binding to ANGPTL3, and lowers cholesterol.

Contact us if interested in this study.

Direct Phone Number*
Email Address*
I Would Prefer To Be Contacted By:
Email Phone
What is the best time to contact you?
*This information is required. It will only be used to contact you regarding ossible participation in a clinica trial.






Copyright 2018, Healthy Heart Cardiology